Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,187 total articles
Julie Diane Jolley, Executive Vice President of Home Health Operations at Enhabit, Inc. (NYSE: EHAB), sold 5,586 shares of the company's common stock on March 9 and March 10, 2026, at $13.63 per share, raising $76,137. After the transactions Jolley directly holds 137,130 shares. The insider sale occurred while EHAB traded close to its 52-week high …
Delek US Holdings director Zohar Shlomo sold 5,000 shares on March 9, 2026, for $41.465 per share, netting about $207,325 and leaving him with 13,989 shares. The transaction was disclosed on a Form 4 filing with the SEC. The sale comes amid a 205% one-year return for the stock and follows Delek US’s Q4 2025 results, which showed an adjusted EPS of …
CoreWeave Chief Development Officer Brannin McBee and affiliated entities sold $34.9 million of Class A shares on March 9, 2026, through a Rule 10b5-1 plan. The transactions spanned prices from $71.72 to $74.32. The company has reported rapid revenue growth and drawn mixed analyst coverage even as the stock trades below its 52-week high.
CoreWeave Chief Development Officer Brannin McBee, acting indirectly through Canis Minor 2025 GRAT, disposed of 19,740 Class A shares on March 9, 2026 under a Rule 10b5-1 plan, generating $1.36 million in proceeds. The same day he converted 18,750 Class B shares into Class A stock. The insider activity occurs as CoreWeave posts significant FY2025 r…
General Atlantic and affiliated entities purchased $50.6 million of Alkami Technology (NASDAQ: ALKT) stock across three transactions from March 9-11, 2026, increasing their combined holdings to 14,879,451 shares. The buying occurred at prices reported between $17.17 and $18.58, while Alkami recently reported mixed fourth-quarter results and several…
Director Raja Bobbili reported the purchase of 250,000 shares of ContextLogic Holdings Inc. (LOGC) in two Form 4 transactions filed with the SEC on March 9 and March 10, 2026. The buys, executed at prices between $7.86 and $8.00 per share and totaling $1,978,252, raise his combined direct and indirect ownership to 18,519,534 shares. The stock is tr…
Equillium, Inc. (NASDAQ: EQ) reported that Senior Vice President and COO Christine Zedelmayer sold a combined 185,937 shares of common stock on February 19, 2026, in transactions that generated $328,104. On the same day she exercised options to acquire 185,937 shares for $141,749. The sale was disclosed on a Form 4 and executed under a Rule 10b5-1 …
Infinite Acquisitions Partners LLC sold 2,350,068 shares of Falcon’s Beyond Global, Inc. (NASDAQ: FBYD) on March 9, 2026, at $6.25 per share for proceeds of $14.69 million and subsequently delivered 2,354,610 shares on March 11, 2026 to meet redemption obligations. After the transactions, Infinite Acquisitions directly holds 21,363,249 Class A shar…
Meta Platforms Chief Operating Officer Javier Olivan sold Class A common stock valued at $987,331 on March 9, 2026, under a pre-arranged Rule 10b5-1 trading plan. The trades occurred at $634.94 per share and involved direct and trust/LLC dispositions. Separately, company announcements and analyst actions highlighted Meta's ongoing AI initiatives an…
Joby Aviation Chief Financial Officer Rodrigo Brumana sold 1,159 shares on March 10, 2026, for $10.25 apiece, netting $11,879. The transaction follows his March 9, 2026 exercise of 2,772 restricted stock units at no cost. The company is conducting FAA-focused flight testing of aircraft N547JX at its Marina, California facility and has won selected …
Trinity Capital Inc. Executive Chairman Steve Louis Brown purchased a total of $31,166 worth of the company's common stock in two transactions executed at $14.82 per share on March 9, 2026. The buys included a direct purchase and an indirect acquisition through a family trust. The transactions follow Trinity Capital's solid fourth-quarter 2025 resu…
Taira Thomas, President of Special Projects at Carvana Co. (NYSE: CVNA), disposed of 953 shares on March 9, 2026, under a Rule 10b5-1 plan, generating $309,725. The move leaves Thomas with 64,997 shares. Since the sale the stock has fallen to $309.59, though it remains higher by 79.7% over the past year despite a 26.7% year-to-date decline. Separat…
Joby Aviation Inc. Chief Policy Officer Gregory Bowles reported the sale of 2,247 shares of common stock for roughly $22,655, according to a Form 4 filing. The transactions took place on March 10-11, 2026, and coincide with recent company milestones including the start of flight testing for its FAA-conforming air taxi, participation in a federal eV…
Guy M. Oliphint, Executive Vice President and Chief Financial Officer of Permian Resources Corp (NYSE: PR), disposed of 11,411 Class A common shares across March 3-4, 2026 in mandatory sell-to-cover transactions totaling roughly $211,188. The trades were reported on a Form 4 filing with the SEC. Permian Resources recently reported Q4 2025 earnings …
Rimini Street Executive Vice President and Chief Financial Officer Michael L. Perica sold 3,140 shares of common stock on March 3, 2026, at $3.7187 per share, netting about $11,676. The same day he exercised options on 6,667 restricted stock units at a $0 transaction price. The sales came as RMNI shares fell 8.4% over the prior week and traded at $…
Permian Resources Corp. Co-Chief Executive Officer and director James H Walter sold 673,425 shares of Class A common stock on March 4, 2026, at a weighted average price of $18.38, totaling $12.38 million. The sale occurred while the share price sits close to a 52-week high of $19.43 after a 57% gain over the last year. Separately, the company repor…
Stephen A. Skaggs, a director at Coherent Corp, disposed of 3,523 shares on March 9, 2026, through a pre-arranged Rule 10b5-1 plan, generating roughly $856,550. The transaction occurred at a weighted average price of $243.1309 per share, with sale prices between $237.90 and $250.00. After the sale Skaggs retains 16,864 shares. Coherent's stock has …
Joby Aviation CEO JoeBen Bevirt sold 3,238 shares on March 10, 2026, for $10.25 per share, netting $33,189. The transactions followed option exercises tied to RSU vesting and leave Bevirt with both direct and substantial indirect holdings. The move occurs as Joby progresses through FAA-focused flight testing, a White House-backed pilot program, and…
Joby Aviation Chief Product Officer Eric Allison sold 2,351 shares on March 10, 2026, and exercised options to acquire 4,559 shares upon RSU vesting on March 9, 2026. Meanwhile, Joby has commenced flight testing of its first aircraft built to FAA Type Inspection Authorization specifications at its Marina, California facility, is participating in a …
Didier Papadopoulos, Joby Aviation's President of Aircraft OEM, sold 3,087 shares of the company's common stock on March 10 and 11, 2026, for a combined total of $31,230. The transactions were reported on a Form 4 and included sales under a 10b5-1 plan. The moves come as Joby progresses flight testing of an FAA-spec aircraft designated N547JX, secu…
Bonny Simi, President of Operations at Joby Aviation, sold 1,727 shares on March 10, 2026, for $10.25 each, a trade totaling $17,701. The transaction follows Simi's exercise of 4,748 RSUs on March 9, 2026, and leaves her with 147,464 shares. The stock has shown strong one-year gains but recent six-month weakness, while the company reports advances …
Kate DeHoff, Chief Legal Officer and Corporate Secretary of Joby Aviation (JOBY), reported the sale of 3,626 shares of common stock for approximately $36,664 in filings with the Securities and Exchange Commission. The transactions, executed on March 10 and March 11, 2026, were accompanied by option exercises tied to vested restricted stock units. T…
Summary: Aquestive Therapeutics Chief People Officer Peter E. Boyd completed a mandated sale of 29,814 common shares on March 10, 2026, while also taking delivery of restricted stock and stock options that vest over three years. The sale, executed under the companys equity incentive plan to meet tax withholding obligations, generated $124,413. Fol…
Aquestive Therapeutics President and CEO Daniel Barber sold 180,677 shares on March 10, 2026, realizing $753,965 at a weighted average price of $4.173. The Form 4 filing also shows acquisitions on March 9, 2026 of 262,000 common shares valued at $0 and 523,000 Non-Qualified Stock Options with a $4.29 exercise price. The insider transaction occurs a…
Melina Cioffi, Senior Vice President of Regulatory Affairs at Aquestive Therapeutics (AQST), sold 25,311 shares on March 10, 2026, for roughly $105,622, according to a Form 4 filing. The filing also shows stock and option grants received days earlier. The company recently reported a larger-than-expected Q4 2025 loss and reiterated its timeline for …
